Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients with Recurrent High Grade Glioma (ABTC 1401)

Grant

Date/time Interval

  • July 17, 2015 - May 16, 2018
  • Total Award Amount

  • 12000.00
  • Direct Costs

  • 8164.00
  • Sponsor Award Id

  • ABTC 1401
  • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Rhodemarie Maron   Investigator  
  • Xiaosi Han   Investigator